High Blood Pressure Screening
High Blood Pressure Screening
High Blood Pressure Screening
Alyssa Matulich
every one out of three adults over the age of 20 have high blood pressure. Most importantly one
out of six people who have high blood pressure do not know they have this condition and high
blood pressure that remains uncontrolled or undetected can lead to other health complications
that can be life-threatening (American Heart Association, 2014). The American Heart
Association lists heart attack, stroke, heart failure, kidney disease or failure, vision loo, sexual
dysfunction. Angina and peripheral artery disease are just a few of the serious health
complication that can be related to uncontrolled high blood pressure. When diagnosing high
blood pressure attention most often is focused on systolic blood pressure, which indicates the
amount of pressure blood is exerting on artery walls as a heart beats as opposed to the diastolic
blood pressure which indicates the pressure blood is exerting on the artery wall while the heart is
resting (American Heart Association, 2014). Both systolic and diastolic pressures can be used
alone to diagnosis high blood pressure but systolic blood pressure, which rises steadily with age,
that is elevated increases the risk for cardiovascular disease for adults over fifty (American Heart
Association, 2014). Sheridan, Pignone, and Donahue (2003) note that 35% of all cardiovascular
events, 49% of all events of heart failure, and 24% of all premature deaths are caused by high
blood pressure. “This substantial burden of suffering from hypertension, in combination with
feasible and accurate means of detection, and a clear benefit from treatment, have led to a
widespread recommendation for screening for hypertension (Sheridan, Pignone, & Donahue,
2003, p. 151).
HIGH BLOOD PRESSURE SCREENING 3
The U.S. Preventative Services Task Force (USPSTF) “makes recommendations about
the effectiveness of specific preventative care services for patients without related signs or
symptoms” (U.S. Preventative Services Task Force [USPSTF], 2015). The recommendations
made by the USPSTF are based on evidence and cost is not considered in the assessment. The
recommendation made by the USPSTF for high blood pressures states screening should be
made in adults 18 years or older and the measurements should be obtained outside of clinical
setting for diagnostic confirmation before beginning treatment (USPSTF, 2015). The USPSTF
has concluded that the benefits of screening for high blood pressure is substantial with little
harmful side effects (2015). The screening interval differs depending on age and risk
assessment of the patient. Adults who are forty years or older with increased risk should be
screened annually while adults ages 18-36 with normal blood pressure, defined as <130/85, and
no risk factors should be screened every 3-5 years (USPSTF, 2015). Most of the research
conducted discusses the screening techniques can be done through office measurements,
ambulatory, and home blood pressure monitoring. There is little discussion in the research about
prevention and screening blood pressures once treatment for hypertension has begun. This paper
will review the literature and discuss the screening and treatment methods discussed in the
Screening Techniques
appropriately side upper arm blood pressure cuff used in combination with a mercury or aneroid
sphygmomanometer (Sheridan et al., 2003). Sheridan et al. (2003) notes that although office
HIGH BLOOD PRESSURE SCREENING 4
blood pressure measuring is a standard way of monitoring blood pressure there are limitations
that come along with it, but ensuring correct measurement will yield a blood pressure that
correlates with intra-arterial measurement which will be highly predictive of cardiovascular risk.
USPSTF recognizes that manual measurement error can include manometer dysfunction,
pressure leaks, stethoscope defects, and cuffs of incorrect width of length according to patient
arm size, observer sensory impairment, inattention, inconsistency recording Korotkoff sounds,
and subconscious bias. Manual blood pressure is gradually being replaced in the clinical setting
in favor of other blood pressure screening techniques. The two primary reasons manual blood
pressure being replaced are mercury, being considered an environmental hazard, and the
clinician error that manual blood pressure is subject to (Myers & Godwin, 2012). Government
bodies worldwide are expressing concern with the use of mercury and gradually banning its use.
In Europe, at least 2 European countries have banned the use of mercury and a European
(Myers & Godwin, 2012). Myers and Godwin (2012) note that in Canada, a directive has been
issued to eliminate mercury from the workplace, though it currently exempts “scientific devices”
which likely would include the mercury sphygmomanometer and in the United States, many
major hospitals no longer use mercury devices. The use of manual blood is also being reduced
because it is subject to human error. The majority of studies conducted on the efficacy and
interpretation of manual blood pressure utilized specifically trained personnel. A research study
was conducted comparing manual blood pressure readings obtained in the community with non-
trained personal and compared results with those taken in the same patient in research studies.
The study found that readings taken in the community setting where on average 10/5 mm HG
higher than those taken in the research study setting (Myers & Godwin, 2012). Organizations
HIGH BLOOD PRESSURE SCREENING 5
such as the Canadian Hypertension Education Programme and American Heart Association have
tried to train healthcare professionals to more accurately take manual BP readings, but their
efforts have not been successful. Because of the limitations in manual office blood pressure
measurement Sheridan et al (2003) recommends that if manual blood pressure is being used in
the diagnosis of hypertension, two or more readings of elevated blood pressure at two or more
visits of a period of several weeks is required and the more measurements obtained will increase
Another important factor to take into consideration when using manual office blood
pressure measurements is the presence of white coat hypertension. Martinez et al (1999) defines
white coat hypertension as blood pressure that is increased in a clinical setting but is found
within normal range at other time outside if the clinic. White coat hypertension has been
estimated to the prevalent between twenty and forty percent of patients who have mild to
moderate hypertension (Martinez et al., 1999). In the study done by Martinez et al it was found
that the frequency of white coat hypertension is inversely proportional to the severity of clinic
blood pressure values and more often associate with females and low education level (1999).
A study by Myers and Goodwin (2013) evaluated the use of automated blood pressure
monitoring as a replacement for manual blood pressure. Automated office blood pressure
monitoring (AOBPM) is the practice of patients taking their own blood pressure in an office
setting using an automated blood pressure machine (Myers & Godwin, 2012). Patients use the
fully automated machine while resting alone in an exam room. The study was conducted to
determine if AOBPM reduced the effects of white coat hypertension and to test the accuracy of
the readings. The readings were specifically compared to automated ambulatory blood pressure
HIGH BLOOD PRESSURE SCREENING 6
monitoring readings, which are considered the gold standard. The BpTURU automated blood
pressure machine set to take readings at 2 minute intervals reduced or eliminated the white coat
response with manual office BP readings and produced similar readings as the awake ambulatory
BP method. Readings taken over 5-10 minutes in two minute intervals reduced office BP by
10.8/3.1 mm HG. Approximately 75% of the decrease was observed within two minutes of the
patient being left alone (Myers & Godwin, 2012). AOBP readings were similar when taken
inside or outside the treatment setting, a significant improvement compared to manual blood
pressure (Myers & Godwin, 2012). Multiple trials found AOBPM readings to be similar to
readings were 10 to 20 mm HG higher (Myers & Godwin, 2012). AOBP is a solution to dealing
with the difference between readings taken inside and outside the trial setting and white coat
hypertension.
Home blood pressure monitoring compared to office blood pressure monitoring can be
more beneficial because home blood pressure assessment provides a better average instead of
periodic monitoring of office measurement (Sheridan et al., 2003). The Canadian Hypertension
Education Program recognizes home blood pressure as superior over office blood pressure
because of the ability to take an average of multiple readings (Myers & Godwin, 2012). In theory
using an automated home blood pressure device at home would decrease the occurrence of white
coat hypertension and allow for more accurate diagnosis of hypertension, but Myers and
Goodwin (2013) found that there was a failure to observe a lower BP when the blood pressure
was taken with a home blood pressure device at home which could be a result of states
stimulation of the patient caused by taking their own blood pressure. Piper et al (2014) states that
HIGH BLOOD PRESSURE SCREENING 7
home monitoring is beneficial because “self-monitoring may improve adherence to treatment and
has been associated with small improvements in BP control, even in the absence of additional
self-management support interventions. It is noted that home blood pressure monitoring can be
“a similar predictor of outcomes” as compared with ambulatory blood pressure, but few studies
and has been found to be a good predictor of clinical cardiovascular outcomes (Sheridan et al.,
2003). Viera, Lingley and Hinderliter (2011) state that because ambulatory blood pressure is
closely associated with prognosis it is considered the gold standard method for determining and
individuals true blood pressure. Piper et al (2014) agrees that ambulatory blood pressure should
be the reference standard for blood pressure monitoring. Ambulatory blood pressure is valuable
because it can confirm suspected white coat hypertension, detect masked hypertension, give an
estimate on how treatment is going among currently treated hypertensive patients and give blood
pressure reading during night-time sleeping hours (Vera, Lingley, & Hinderliter, 2011). As with
the above methods of blood pressure monitoring, ambulatory blood pressure monitoring also has
its limitations. In order to acquire an ambulatory blood pressure assessment, the patient has to
wear a blood pressure cuff on their arm for an entire twenty-four-hour period as well as a
monitor unit on their waist. In the study completed by Viera et al (2011) patients complained that
the monitor kept them from falling asleep and woke them up from sleep with blood pressure
measurement. Skin irritation, pain and bruising were also common complaints found by patient
who completed the study which lead to removal of the blood pressure monitor (Vera et al.,
2011). Another factor to take into consideration when using ambulatory blood pressure is the
HIGH BLOOD PRESSURE SCREENING 8
high monetary cost associated with the assessment. Sheridan et al (2003) noted that because of
the high monetary costs research done of ambulatory blood pressure is limited. Even with the
high costs of doing the ambulatory blood pressure Sheridan et al (2003) does note the benefit of
determining patient with white coat hypertension because, “many patients who have elevated
clinic blood pressures had normal ambulatory blood pressure.” Overall the studies conducted on
ambulatory blood pressure found that the measurements acquired were more reliable but the
method in which the measurements were achieved were the least preferred method of measuring
References
American Heart Association. (2014). Understanding Blood Pressure Readings. Retrieved from
http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/KnowYourNumbers/
Understanding-Blood-Pressure-Readings_UCM_301764_Article.jsp#.WXD4PxjMz-Y
Martinez, M. A., Garcia-Puig, J., Martin, J. C., Guallar-Castillion, P., Aguirre de Carcer, A.,
Torre, A., ... Madero, R. S. (1999). Frequency and determinants of white coat
Myers, M. G., & Godwin, M. (2012). Review Automated Office Blood Pressure. Canadian
Piper, M. A., Evans, C. V., Burda, B. U., Margolis, K. L., O'Connor, E., SMith, N., ... Whitlock,
E. P. (2014). Screening for high blood pressure in adults:a systematic evidence review for
the U.s. Preventative Services Task Force. Agency for Healthcare Research and Quality,
13(121).
Sheridan, S., Pignone, M., & Donahue, K. (2003). Screening for high blood pressure a review of
the evidence for the U.S. preventative services task force. American Journal of
Spruill, T. M., Feltheimer, S. D., Harlapur, M., Schwartz, J. E., Ogedegbe, G., Park, Y., & Gerin,
U.S. Preventative Services Task Force. (2015). Screening for high blood pressure in adults: U.S.
Vera, A. J., Lingley, K., & Hinderliter, A. L. (2011). Tolerablitiy of the Oscar 2 ambulatory
http://www.biomedcenteral.com/147-2288/11/59